Table of Contents

2019-2024 Global Darunavir Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Darunavir Market Size 2014-2024
  • 2.1.2 Darunavir Market Size CAGR by Region
• 2.2 Darunavir Segment by Type
  • 2.2.1 Tablet
  • 2.2.2 Oral suspension
• 2.3 Darunavir Market Size by Type
  • 2.3.1 Global Darunavir Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Darunavir Market Size Growth Rate by Type (2014-2019)
• 2.4 Darunavir Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Drug store
• 2.5 Darunavir Market Size by Application
  • 2.5.1 Global Darunavir Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Darunavir Market Size Growth Rate by Application (2014-2019)

3 Global Darunavir by Players

• 3.1 Global Darunavir Market Size Market Share by Players
  • 3.1.1 Global Darunavir Market Size by Players (2017-2019)
  • 3.1.2 Global Darunavir Market Size Market Share by Players (2017-2019)
• 3.2 Global Darunavir Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Darunavir by Regions

• 4.1 Darunavir Market Size by Regions
• 4.2 Americas Darunavir Market Size Growth
• 4.3 APAC Darunavir Market Size Growth
• 4.4 Europe Darunavir Market Size Growth
• 4.5 Middle East & Africa Darunavir Market Size Growth

5 Americas

• 5.1 Americas Darunavir Market Size by Countries
• 5.2 Americas Darunavir Market Size by Type
• 5.3 Americas Darunavir Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Darunavir Market Size by Countries
• 6.2 APAC Darunavir Market Size by Type
• 6.3 APAC Darunavir Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Darunavir by Countries
• 7.2 Europe Darunavir Market Size by Type
• 7.3 Europe Darunavir Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Darunavir by Countries
• 8.2 Middle East & Africa Darunavir Market Size by Type
• 8.3 Middle East & Africa Darunavir Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Darunavir Market Forecast

• 10.1 Global Darunavir Market Size Forecast (2019-2024)
• 10.2 Global Darunavir Forecast by Regions
  • 10.2.1 Global Darunavir Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Darunavir Forecast by Type
• 10.8 Global Darunavir Forecast by Application

11 Key Players Analysis

• 11.1 Janssen Therapeutics
  • 11.1.1 Company Details
  • 11.1.2 Darunavir Product Offered
  • 11.1.3 Janssen Therapeutics Darunavir Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Janssen Therapeutics News
• 11.2 Mylan
  • 11.2.1 Company Details
  • 11.2.2 Darunavir Product Offered
  • 11.2.3 Mylan Darunavir Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Mylan News
• 11.3 Teva
  • 11.3.1 Company Details
  • 11.3.2 Darunavir Product Offered
  • 11.3.3 Teva Darunavir Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Teva News
• 11.4 Cipla
  • 11.4.1 Company Details
  • 11.4.2 Darunavir Product Offered
  • 11.4.3 Cipla Darunavir Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Cipla News
• 11.5 Lupin
  • 11.5.1 Company Details
  • 11.5.2 Darunavir Product Offered
  • 11.5.3 Lupin Darunavir Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Lupin News
• 11.6 Hetero
  • 11.6.1 Company Details
  • 11.6.2 Darunavir Product Offered
  • 11.6.3 Hetero Darunavir Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Hetero News

...

12 Research Findings and Conclusion

Darunavir (DRV), sold under the brand name Prezista among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.

According to this study, over the next five years the Darunavir market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Darunavir business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Darunavir market by product type, application, key companies and key regions.

This study considers the Darunavir value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Tablet
Oral suspension
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Drug store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Janssen Therapeutics
Mylan
Teva
Cipla
Lupin
Hetero
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Darunavir market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Darunavir market by identifying its various subsegments.
Focuses on the key global Darunavir players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Darunavir with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Darunavir submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.